ليست عنوان مقالات لاتين Antispasmodic effect of Dracocephalum kotschyi hydroalcoholic extract on rat ileum contraction Anxiety, conscious awareness and change detection

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Antispasmodic effect of Dracocephalum kotschyi hydroalcoholic extract on rat ileum contraction

2

Antispasmodic effect of hydroalcoholic and flavonoids extracts of Dracocephalum kotschyi on rabbit bladder

3

Antispasmodic effect of osthole and Prangos ferulacea extract on rat uterus smooth muscle motility

4

Antispasmodic effect of Physalis alkekengi fruit extract on rat uterus

5

Antispasmodic Effect of Zataria multiflora Boiss. Leaf Extract on the Rat Uterus

6

Antispasmodic Effects of Aqueous and Hydroalcoholic Punica granatum Flower Extracts on the Uterus of Non-pregnant Rats

7

Antispasmodic effects of Citrus aurantium flowers aqueous extract on uterus of non-pregnant rats

8

Antispasmodic effects of hydroalcoholic, aqueous, chloroform, and ethyl acetate extracts of Zaringiah on rabbit ileum smooth muscle contractions

9

Antispasmodic effects of Prangos ferulacea acetone extract and its main component osthole on ileum contraction

10

Anti-speeding Israeli doctors

11

Antisperm antibody formation following Vasectomy

12

Anti-spermatogenic activities of Taraxacum officinale whole plant and leaves aqueous extracts

13

Antisperms antibodies in infertile males attending a Tertiary Care Hospital in Karachi

14

Anti-staling effects of β-glucan and barley flour in wheat flour chapatti

15

Antistatic ability of 1-n-tetradecyl-3-methylimidazolium bromide and its effects on the structure and properties of polypropylene

16

Anti-static additive for pressure-sensitive adhesives and its effect on light leakage in liquid crystal display

17

Antistatic and Thermal Properties of Poly(Lactic Acid)/ Polypropylene/Carbon Nanotube Nanocomposites

18

Antistatic behavior of PAN-based low-temperature carbonaceous fibers

19

Anti-static charge character of the plasma treated polyester filter fabric

20

Antistatic coating and electromagnetic shielding properties of a hybrid material based on polyaniline/organoclay nanocomposite and EPDM rubber

21

Antistatic modification of polypropylene by incorporating Tween/modified Tween

22

Antistatic performance and morphological observation of ternary blends of poly(ethylene terephthalate), poly(ether esteramide), and Na-neutralized poly(ethylene-co-methacrylic acid) copolymers

23

Antistatic thermoplastic blend of polyaniline and polystyrene prepared in a double-screw extruder

24

Antisteroidogenic Activity of Ethanol Extract of Ammania baccifera (L.) Whole Plant in Female Albino Mice Ovaries

25

Anti-sticking treatment for a nanoimprint stamp

26

Anti-Stokes and Stokes photoluminescence in non-uniform GaAs-based quantum wells

27

Anti-Stokes emission in LaCl3 doped with U3+ and Pr3+ ions

28

Anti-Stokes fluorescent cooling by energy transfer

29

Anti-Stokes luminescence tail in porous Si

30

Anti-Stokes photoluminescence and structural defects in CdSe/ZnSe nanostructures

31

Anti-Stokes photoluminescence between Inx(Al0.17Ga0.83)1−xAs/Al0.17Ga0.83As quantum wells with different x values

32

Anti-Streptococcus pyogenes Activity of Selected Medicinal Plant Extracts Used in Thai Traditional Medicine

33

Anti-streptokinase Antibody Detection before and Immediately after Streptokinase Therapy in Patients with Myocardial Infarction

34

Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients

35

Anti-stress and anti-allergic effect of Actiniopteris radiata in some aspects of asthma

36

Anti-Stress and Anti-Amnesic Effects of Coriandrum sativum Linn (Umbelliferae) Extract – an Experimental Study in Rats

37

Antistress Effect of TRPV1 Channel on Synaptic Plasticity and Spatial Memory

38

ANTISUPERCYCLIC OPERATORS AND ORBITS OF THE VOLTERRA OPERATOR

39

Anti-survivin antibody responses in lung cancer

40

Anti-Sway Control Schemes of a Boom Crane Using Command Shaping Techniques

41

Anti-Sway System for Container Cranes with Coordinated Motion Control and Reduced Dynamic Loads

42

Anti-swing and positioning control of overhead traveling crane

43

Anti-swing Fuzzy Controller Design for a 3D Overhead Crane

44

Antisymbiosis. Preferential coordination of anionic oxygen versus neutral sulfur donor atoms of methylsulfanyl- or methylsulfinyl-acetato, 2-benzoato and 2-phenolato to the cis-PtII(PPh3)2 and PtII(dppe) residues

45

Antisymmetric and other subleading corrections to scaling in the local potential approximation Original Research Article

46

Anti-symmetric angle-ply laminated thick cylindrical panels

47

Antisymmetric capillary waves in electrified fluid sheets

48

Antisymmetric exchange and pseudo Jahn–Teller instability in spin-frustrated metal clusters

49

Antisymmetric exchange interaction, magnetoelectric and magnetodielectric response in structurally distorted G-type antiferromagnetic perovskite: La0.9Gd0.1FeO3 Original Research Article

50

Antisymmetric flows and edge-connectivity Original Research Article

51

Antisymmetric flows and strong oriented coloring of planar graphs Original Research Article

52

Antisymmetric flows in matroids

53

Antisymmetric Grating Coupler: Experimental Results

54

Anti-symmetric mode vibration of a curved beam subject to autoparametric excitation

55

Anti-symmetric periodic solutions for the third order differential systems

56

Antisymmetric resonant vibrational transition polarizabilities for even-electron molecules

57

Antisymmetric tensor field on AdS5

58

Antisymmetric vibrations of multilayered conical shells with constrained viscoelastic layers

59

Anti-symmetrically fused model and non-linear integral equations in the three-state Uimin-Sutherland model Original Research Article

60

Antisymmetrized Green’s function approach to (e, e′) reactions with a realistic nuclear density

61

Antisymmetrized molecular dynamics for heavy ion collisions

62

Antisymmetrized Molecular Dynamics: a new insight into the structure of nuclei

63

Antisymplectic gauge theories Original Research Article

64

Anti-synchronization and synchronization of T-system

65

Anti-synchronization control of a class of memristive recurrent neural networks

66

Anti-synchronization in different chaotic systems

67

Anti-synchronization in two non-identical hyperchaotic systems with known or unknown parameters

68

Anti-Synchronization of Complex Chaotic T-System Via Optimal Adaptive Sliding-Mode and Its Application In Secure Communication

69

Anti-synchronization of fractional-order chaotic complex systems with unknown parameters via adaptive control

70

Anti-synchronization of two different chaotic systems

71

Anti-synchronization of two hyperchaotic systems via nonlinear control

72

Anti-synchronization of uncertain unified chaotic systems with dead-zone nonlinearity Original Research Article

73

Antitachycardia Pacing for Very Fast Ventricular Tachycardia and Low-Energy Shock for Ventricular Arrhythmias in Patients With Implantable Defibrillators

74

Antitachycardia Pacing in Patients With Implantable Cardioverter-Defibrillators: Inverse Circadian Variation of Therapy Success and Acceleration

75

Antitachycardia Pacing: Which Patients and Which Methods?

76

Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer

77

Anti-termination by SIV Tat Requires Flexibility of the Nascent TAR Structure

78

Anti-termite activity of essential oil and its components from Myristica fragrans against Microcerotermes beesoni

79

Anti-termite activity of essential oil and its components from Myristica fragrans against Microcerotermes beesoni

80

Anti-termite efficacy of Capparis decidua and its combinatorial mixtures for the control of Indian white termite Odontotermes obesus (Isoptera: Odontotermitidae) in Indian soil

81

Anti-termitic activities of essential oils from coniferous trees against Coptotermes formosanus

82

ANTI-TERRORISM FINANCING LAWS IN MALAYSIA: CURRENT TRENDS AND DEVELOPMENTS

83

Anti-tert-butylperoxyl radical reactivities of copper(II), manganase(II), and iron(III) 3,5-diisopropylsalicylate chelates

84

Antitetanus Toxoid Antibody Titer of Chronic Hemodialysis Patients in Iran

85

Anti-TGFβ1 antibody for modulation of expression of endogenous transforming growth factor beta 1 to prevent fibrosis after plastic surgery in rats

86

Anti-Thermal-Fatigue Property of 8407 Steel With Surface Aluminization and Oxidation Treatment Original Research Article

87

Antithesis as Leverage in Russian Political Discourse

88

Antithetic fault linkages in a deep water fold and thrust belt

89

Antithetic linkage between oblique Quaternary thrusts at the Andean front, Argentine Precordillera

90

Antithetic lognormal/normal random variables

91

Antithetic Markov Chain Monte Carlo Algorithm and Computing Dominant Eigenpair: Variance Reduction Approach

92

Antithetical product situation in the femtosecond and nanosecond photoionization of sterically hindered phenols in non-protic solvents

93

Anti-thixotropic properties of waxy maize starch dispersions with different pasting conditions

94

Anti-thixotropic properties of waxy maize starch dispersions with different pasting conditions

95

Antithrombin (human) concentrate infusion in pediatric patients with >50% TBSA burns

96

Antithrombin activity during the period of percutaneous coronary revascularization : Relation to heparin use, thrombotic complications and restenosis

97

Antithrombin Alternatives: Low Molecular Weight Heparins, Direct ANtithrombins, Xa Inhibitors and More

98

Antithrombin deficiency and its relationship to severe burns

99

ANTITHROMBIN III AS MARKER OF FIBROSIS IN CHRONIC HEPATITIS C

100

Antithrombin III attenuates pulmonary tissue injury caused by mesenteric ischemia-reperfusion

101

Antithrombin III concentrate in the acute phase of thermal injury

102

Antithrombin III Enhances Inducible Nitric Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells

103

Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in mice

104

Antithrombin III prevents deleterious effects of remote ischemia-reperfusion injury on healing of colonic anastomoses

105

Antithrombin III suppresses ADP-induced platelet granule secretion: Inhibition of HSP27 phosphorylation

106

Antithrombin-III as a Non-Invasive Marker of Chronic Liver Disease

107

Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta+5)O2 thin films

108

Antithrombotic activity of 12 table grape varieties. Relationship with polyphenolic profile

109

Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii)

110

Antithrombotic agents: From RGD to peptide mimetics Review Article

111

Antithrombotic and antifibrinolytic effects of antithrombin III replacement in liver cirrhosis

112

Antithrombotic and antihemolytic effects of Lagerstroemia speciosa (Lythraceae) aqueous extract

113

Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings

114

Antithrombotic and profibrinolytic activities of isorhamnetin-3-O-galactoside and hyperoside

115

Antithrombotic and profibrinolytic activities of phloroglucinol

116

Antithrombotic and prothrombotic activities of the vascular endothelium

117

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

118

Antithrombotic drug therapy after infrainguinal vascular surgery

119

Antithrombotic effect of ligustrazine hydrochloride injection on the model of induced arteriovenous shunt thrombosis

120

Antithrombotic effects of Abciximab

121

Antithrombotic function of atrial endocardium: Effects of risk factors and atrial fibrillation

122

Antithrombotic Management and 1-Year Outcome of Patients on Oral Anticoagulation Undergoing Coronary Stent Implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry)

123

Antithrombotic property of an aqueous extract from Pseudocedrela kotschyi and Adenia cissampeloides

124

Antithrombotic prophylaxis in children and adolescent patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians

125

Antithrombotic Regimens in Patients With Atrial Fibrillation and Coronary Disease: Optimizing Efficacy and Safety

126

Antithrombotic strategies for the management of non-valvular atrial fibrillation

127

Antithrombotic Strategies to Reduce Adverse Clinical Outcomes in Patients With Acute Coronary Syndrome

128

Antithrombotic therapy after prosthetic cardiac valve implantation: Potential novel antithrombotic therapies

129

Antithrombotic therapy for acute myocardial infarction

130

Antithrombotic therapy for prevention of stroke in clinical practice in the ED

131

Antithrombotic Therapy in the Elderly

132

Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction

133

Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: A review of the available evidence and practical suggestions for the clinician

134

Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease: A Nationwide Cohort Study

135

Antithrombotic treatment in patients with unstable coronary artery disease undergoing CABG

136

Antithrombotic treatment in patients with unstable coronary artery disease undergoing CABG: Reply

137

Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events

138

Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registry

139

Antithrombotics for left-ventricular impairment

140

Antithrombotics for left-ventricular impairment?

141

Antithrombotics in Acute Coronary Syndromes

142

Antithrombotics; enzyme inhibitor; heparin; oligosaccharides; thrombin

143

Anti-Thy-1 monoclonal antibody with specific reactivity with vascular endothelial cells in rat glomeruli

144

Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection

145

Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells

146

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

147

Antithymocyte globulin treatment of orbital Wegener granulomatoi: a follow-up tudy

148

Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome

149

Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell—depleted grafts from matched unrelated donors: A dose-finding study

150

Antithyroid drug or hypothyroidism causes cellular damage inthe renal cortex of adult male albino rats: a histological andimmunohistochemical study

151

Antithyroid Drugs

152

Antithyroid drugs and Graves disease - prospective randornized assessment of long-term treatment

153

Anti-Thyroid Drugs-Related Myopathy: Is Carbimazole the Real Culprit?

154

Anti-Thyroid Peroxidase and Risk of Recurrent Spontaneous Abortion

155

Anti-Thyroid Peroxidase and Risk of Recurrent Spontaneous Abortion

156

Antithyroid peroxidase antibodies in women with polycystic ovary syndrome

157

Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease

158

Anti-TNF Antibodies Associated with Different Risk of Latent Tuberculosis Activation

159

Anti-TNF therapies—the hope of tomorrow

160

Anti-TNF therapy and plasma HDL cholesterol concentration

161

Anti-TNF yields a block-buster

162

Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion

163

Anti-TNFα Biologics in the Pharmacotherapy of Rheumatoid Arthritis: Effectiveness and Safety of Infliximab, Adalimumab and Etanercept

164

Anti-TNF-α therapy does not ameliorate disease in a model of acute virus-endotoxin mediated respiratory disease in pigs

165

Anti-TNF-α therapy does not ameliorate disease in a model of acute virus-endotoxin mediated respiratory disease in pigs

166

Anti-TNFα therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat

167

Anti-TNF-α therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis

168

Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes

169

Anti-TNFα treatment and reactivation of latent tuberculosis

170

Anti-topoisomerase I autoantibodies in systemic sclerosis

171

Anti-tourist attitudes: Mediterranean charter tourism

172

Antitoxin approach to malaria

173

Antitoxin vaccine could provide new way to fight malaria

174

Anti-Toxocara Seropositivity in the Patients with Eye Diseases in Ophthalmology Clinics in Tehran, Iran

175

Anti-Toxoplasma Activity of 2-(Naphthalene-2-γlthiol)-1H Indole.

176

Anti-Toxoplasma Activity of Tellurium Oxide (TeO2) Nanoparticle on Toxoplasma gondii In vitro

177

Anti-Toxoplasma Effect of Hydroalchohlic Extract of Terminalia chebula Retz in Cell Culture and Murine Model

178

Anti-Toxoplasma Effects of Silver Nanoparticles Based on Ginger Extract: An in Vitro Study

179

Anti-Toxoplasma gondii activity of 5-oxo-hexahydroquinoline derivatives: synthesis, in vitro and in vivo evaluations, and molecular docking analysis

180

Anti-Toxoplasma gondii Antibody Levels in Blood Supply of Shiraz Blood Transfusion Institute, Iran.

181

Anti-toxoplasmosis activity of herbal medicines: Narrative review

182

Anti-trade-off in dehydration of ethanol by novel PVA/APTEOS hybrid membranes

183

Anti-trafficking law stalls in Russian parliament

184

Anti-transforming nature of ascorbic acid and its derivatives examined by two-stage cell transformation using BALB/c 3T3 cells

185

Anti-triangular and anti-m-Hessenberg forms for Hermitian matrices and pencils Original Research Article

186

Anti-Trichinella IgG in ethnic minorities living in Trichinella-endemic areas in northwest Vietnam: Study of the predictive value of selected clinical signs and symptoms for the diagnosis of trichinellosis

187

Anti-Trichomonas Vaginalis Activity of Ethanolic Extracts of Medicago Sativa and Satureja Hortensis, In Vitro Study

188

Anti-Trichomonas vaginalis Effect of Methanolic Extracts of Sambucus nigra in Comparison with Metronidazole

189

Anti-Triiodothyronine Auto-Antibody Interference in Recent Free Thyroid Hormone Assays

190

Antitrombotik ve Antikoagülan Kullanım İlkeleri

191

Antitrust and technological innovation in the US: ideas, institutions, decisions, and impacts, 1890–2000

192

Anti-trust approval for OEP to buy-out DC Chemicalsʹ stake in Columbian

193

Antitrust Concerns About Evolving Vertical Relationships in Health Care

194

Antitrust Enforcement in the Electricity and Gas Industries: Problems and Solutions for the EU

195

Antitrust environment and innovation

196

Antitrust Issues and the Restructuring of the Power Industry

197

Antitrust issues in international comparisons of market structure

198

Antitrust Regulation before the Sherman Act: The Break-up of the Chicago Gas Trust Company

199

Antitrust Update: The Robinson-Patman Act Rides Again and Mergers Come Under Increased Scrutiny

200

Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds

201

Anti-Trypanosoma cruzi activity of 10 medicinal plants used in northeast Mexico

202

Anti-Trypanosoma cruzi Activity of Extracts from Argentinean Asteraceae Species

203

Anti-Trypanosoma cruzi activity of nicotinamide

204

Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides

205

Anti-trypanosomal activities of DNA topoisomerase inhibitors

206

Anti-trypanosomal Activity of Piper Nigrum L (Black pepper) Against Trypanosoma Evansi

207

Antitrypanosomal activity of quaternary naphthalimide derivatives

208

Antitrypanosomal and Cytotoxic Activities of Selected Medicinal Plants and Effect of Cordyline terminalis on Trypanosomal Nuclear and Kinetoplast Replication

209

Antitrypanosomal Effects of Brassica Oleracea (Cabbage) Fruits and Leaves

210

Antitrypanosomal pyridoacridine alkaloids from the Australian ascidian Polysyncraton echinatum

211

Antitubercular Activity and Isolation of Chemical Constituents from plant Vitex negundo Linn

212

Antitubercular Activity and the Subacute Toxicity of (−)-Licarin A in BALB/c Mice: A Neolignan Isolated from Aristolochia taliscana

213

Antitubercular Activity of the Fungus Gliocladium sp. MR41 Strain

214

Antitubercular agents. Part 1: Synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents

215

Antitubercular agents. Part 2: New thiolactomycin analogues active against Mycobacterium tuberculosis

216

Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity Original Research Article

217

Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines

218

Antitubercular and Phytochemical Investigation of Methanol Extracts of Medicinal Plants Used by the Samburu Community in Kenya

219

Antitubercular drugs: new drugs designed by molecular modifications

220

Anti-tuberculosis and cytotoxic evaluation of the seaweed Sargassum boveanum

221

Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002

222

Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis

223

Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis

224

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism

225

Antituberculosis Drug-induced Linear IgA Dermatosis

226

Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome

227

Antituberculosis drugs: Ten years of research Review Article

228

anti-Tuberculosis natural products: synthesis and biological evaluation of pyridoacridine alkaloids related to ascididemin

229

Antituberculous activity of some aryl semicarbazone derivatives

230

Antituberculous therapy and acute liver failure

231

Antituberculous therapy and acute liver failure

232

Anti-tuberculous therapy and acute liver failure

233

Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation Original Research Article

234

Anti-tumor abietane diterpenes from the cones of Sequoia sempervirens

235

Anti-tumor actions of major component 3′-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation

236

Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules

237

Antitumor activities of a newly synthesized shikonin derivative, 2-hyim-DMNQ-S-33

238

Antitumor activities of different fractions of polysaccharide purified from Ornithogalum caudatum Ait

239

Antitumor activities of different fractions of polysaccharide purified from Ornithogalum caudatum Ait

240

Antitumor Activities of Green Tea by Up-regulation of miR-181a Expression in LNCaP Cells Using 3D Cell Culture Model

241

Antitumor activities of heteropolysaccharides of Poria cocos mycelia from different strains and culture media

242

Antitumor activities of quercetin and quercetin-5′,8-disulfonate in human colon and breast cancer cell lines

243

Antitumor activities of recombinant human interferon (IFN)-λ1 in vitro and in xenograft models in vivo for colon cancer

244

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

245

Antitumor activities of vanadium(IV), manganese(IV), iron(III), cobalt(II) and copper(II) complexes of 2-methylaminopyridine

246

Antitumor activities of α-, β-monogalactosylceramides and four diastereomers of an α-galactosylceramide

247

Anti-tumor Activity and Cell Cycle Arrest of a New Diterpene Ester from Daphne mucronata Using K562 Cells

248

Antitumor activity and COMPARE analysis of bis-indole derivatives Original Research Article

249

Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya Original Research Article

250

Antitumor Activity and in vivo Antioxidant Status of Mucuna pruriens (Fabaceae) Seeds against Ehrlich Ascites Carcinoma in Swiss Albino Mice

251

Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives

252

Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43)

253

Antitumor activity and toxicity relationship of annonaceous acetogenins

254

Antitumor Activity In Vitro Provided by N-Alkyl-Nitroimidazole Compounds

255

Antitumor activity of 4-amino and 8-methyl-4-(3diethylamino propylamino)pyrimido[4′,5′:4,5]thieno (2,3-b) quinolines

256

Antitumor activity of 4-phenyl-1-arylsulfonylimidazolidinone, DW2143

257

Anti-tumor activity of a 3-oxo derivative of oleanolic acid

258

Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo

259

Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin

260

Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine

261

Antitumor activity of a polysaccharide from Pleurotus eryngii on mice bearing renal cancer

262

Anti-tumor activity of a recombinant soluble Fzd7 decoy receptor in human gastric and colon cancer cells

263

Anti-tumor activity of an ICAM-3 antibody (ICM3) Against human leukemic xenograft tumors in nude mice

264

Antitumor activity of diethynylfluorene derivatives of gold(I) Original Research Article

265

Anti-tumor activity of Fe (III), Co(II) and Pd(II) complexes of N3- {phenyl [(4-pyridylcarbonyl)amino]methyl}

266

Anti-tumor Activity of Ferulago angulata Boiss. Extract in Gastric Cancer Cell Line via Induction of Apoptosis

267

Antitumor activity of four macrocyclic ellagitannins from Cuphea hyssopifolia

268

Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma

269

Antitumor activity of glycyrol via induction of cell cycle arrest, apoptosis and defective autophagy

270

Antitumor activity of G-quadruplex–interactive agent TMPyP4 in K562 leukemic cells

271

Antitumor activity of HER-2 inhibitors

272

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

273

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

274

Antitumor activity of interleukin 12 against interleukin 2-transduced mouse glioma cells

275

Antitumor Activity of Kielmeyera Coriacea Leaf Constituents in Experimental Melanoma, Tested in Vitro and in Vivo in Syngeneic Mice

276

Antitumor activity of methoxylated flavonoids separated from Achillea fragrantissima extract in Ehrlich’s ascites carcinoma model in mice

277

Anti-tumor activity of nanoliposomes containing crude extract of saffron in mice bearing C26 colon carcinoma

278

Anti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets

279

Antitumor activity of novel fluoro-substituted (–)-epigallocatechin-3-gallate analogs

280

Anti-tumor activity of N-thiolated β-lactam antibiotics

281

Anti-tumor activity of paclitaxel-loaded chitosan nanoparticles: An in vitro study

282

Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines

283

Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24]•3H2O, against, human gastric cancer model

284

Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo

285

Antitumor Activity of Prosopis glandulosa Torr. on Ehrlich Ascites Carcinoma (EAC) Tumor Bearing Mice

286

Anti-Tumor Activity of Salvia officinalis is Due to Its Anti-Angiogenic, Anti-Migratory and Anti-Proliferative Effects

287

Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines Original Research Article

288

Antitumor activity of sulfated extracellular polysaccharides of Ganoderma lucidum from the submerged fermentation broth

289

Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G

290

Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro

291

Anti-tumor activity of the crude saponins obtained from asparagus

292

Anti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa Original Research Article

293

Antitumor activity of the marine natural product dibromophakellstatin in vitro

294

Anti-tumor activity of the novel angiogenesis inhibitor anginex

295

Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum

296

Antitumor activity of tributyrin in murine melanoma model

297

Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters

298

Antitumor activity of unsaturated fatty acid esters of 4′-demethyldeoxypodophyllotoxin

299

Antitumor activity of vanadocene Y and its selenocyanate derivative in xenografted caki-1 tumors in mice

300

Antitumor activity studies of newly synthesized N-salicyloyl-N′-(p-hydroxybenzthioyl)hydrazine and its Copper(II) complex both in vivo and in vitro Original Research Article

301

Antitumor agents 171. Cytotoxicities of lobatosides B, C, D, and E, cyclic bisdesmosides isolated from Actinostemma lobatum maxim

302

Antitumor agents 1871: Synthesis and cytotoxicity of substituted 8,8-dimethyl-2H,8H-pyrano[6,5-h]quinoline-2-one and related compounds

303

Antitumor agents 200.1 cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives

304

Antitumor agents 201.1 Cytotoxicity of harmine and β-carboline analogs

305

Antitumor agents 210. synthesis and evaluation of taxoid–epipodophyllotoxin conjugates as novel cytotoxic agents Original Research Article

306

Antitumor agents 216. Synthesis and evaluation of paclitaxel–camptothecin conjugates as novel cytotoxic agents Original Research Article

307

Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives Original Research Article

308

Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents Original Research Article

309

Antitumor agents 251: Synthesis, cytotoxic evaluation, and structure–activity relationship studies of phenanthrene-based tylophorine derivatives (PBTs) as a new class of antitumor agents Original Research Article

310

Anti-tumor agents 255: Novel glycyrrhetinic acid–dehydrozingerone conjugates as cytotoxic agents Original Research Article

311

Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents Original Research Article

312

Antitumor agents. 1771. Design, syntheses, and biological evaluation of novel etoposide analogs bearing pyrrolecarboxamidino group as DNA topoisomerase II inhibitors

313

Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: Evaluation of novel conjugates as cytotoxic agents

314

Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant—taxoid conjugates as novel cytotoxic agents

315

Antitumor agents. Part 186: Synthesis and biological evaluation of demethylcolchiceinamide analogues as cytotoxic DNA topoisomerase II inhibitors Original Research Article

316

Antitumor agents. Part 202: Novel 2′-amino chalcones: design, synthesis and biological evaluation

317

Antitumor Agents. Part 204:[] Synthesis and Biological Evaluation of Substituted 2-Aryl Quinazolinones

318

Antitumor agents. Part 209: Pheophorbide-a derivatives as photo-Independent cytotoxic agents Original Research Article

319

Antitumor agents. Part 212: Bucidarasins A–C, three new cytotoxic clerodane diterpenes from Bucida buceras

320

Antitumor Agents. Part 214: Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents Original Research Article

321

Antitumor agents. Part 215:: Antitubulin effects of cytotoxic B-Ring modified allocolchicinoids

322

Antitumor agents. Part 218: Cappamensin A, a new In vitro anticancer principle, from Capparis sikkimensis

323

Antitumor agents. Part 226: synthesis and cytotoxicity of 2-Phenyl-4-quinolone acetic acids and their esters

324

Antitumor agents. Part 227: Studies on novel 4′-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II Original Research Article

325

Antitumor agents. Part 230: C4′-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors

326

Antitumor agents. Part 232: Synthesis of cyclosulfite podophyllotoxin analogues as novel prototype antitumor agents

327

Antitumor agents. Part 235: Novel 4′-ester etoposide analogues as potent DNA topoisomerase II inhibitors with improved therapeutic potential Original Research Article

328

Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives

329

Antitumor agents. Part 3: synthesis and cytotoxicity of new trans-Stilbene benzenesulfonamide derivatives

330

Antitumor agents—CLXVII. Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-epoxypropylamino)-9,10-anthracenedione, and of related compounds Original Research Article

331

Antitumor agents—CLXXIII. Synthesis and evaluation of camptothecin-4β-amino-4′-O-demethyl epipodophyllotoxin conjugates as inhibitors of mammalian DNA topoisomerases and as cytotoxic agents Original Research Article

332

Antitumor agents—CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis Original Research Article

333

Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells Original Research Article

334

Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model

335

Antitumor and Antiangiogenic Effects of the Crude Oil of Nigella sativa L. in Tumor Tissues in BALB/c Mice

336

Antitumor and antimetastatic activities of grape skin polyphenols in a murine model of breast cancer

337

Antitumor and antimetastatic effect of warfarin and heparins

338

Antitumor and antimicrobial activities of Fe(II)/Fe(III) complexes derived from some heterocyclic compounds Original Research Article

339

Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models

340

Antitumor and antioxidant activities of levan and its derivative from the isolate Bacillus subtilis NRC1aza

341

Antitumor and immunomodulatory activities of a polysaccharide from Artemisia argyi

342

Antitumor and Immunomodulatory Activities of Peganum harmala Extracts

343

Antitumor and immunomodulatory activity of a water-soluble low molecular weight polysaccharide from Schisandra chinensis (Turcz.) Baill

344

Antitumor and immunomodulatory activity of polysaccharides from Sargassum fusiforme

345

Antitumor and immunomodulatory activity of water-soluble polysaccharide from Inonotus obliquus

346

Antitumor and immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in mice

347

Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice

348

Antitumor and immunostimulatory activity of a polysaccharide–protein complex from Scolopendra subspinipes mutilans L. Koch in tumor-bearing mice

349

Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells Original Research Article

350

Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status

351

Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice

352

Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov.

353

Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells Original Research Article

354

Antitumor applications of nanotraditional Chinese medicine

355

Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH

356

Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH

357

Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods

358

Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice

359

Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts

360

Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer

361

Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells

362

Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: In vitro and in vivo study

363

Antitumor effect of fibroblast engineered to express fas ligand (FasL) on hepatocellular carcinoma (HCC)

364

Antitumor effect of gefitinib (‘Iressa’) on esophageal squamous cell carcinoma cell lines in vitro and in vivo

365

Anti-tumor Effect of Ginkgo biloba Exocarp Extracts on B16 Melanoma Bearing Mice Involving P I3K/Akt/HIF-1α/VEGF Signaling Pathways

366

Antitumor effect of l-deprenyl in rats with carcinogen-induced mammary tumors

367

Anti-Tumor Effect of Marshallagia marshalli Somatic Antigen on Inhibition Cell Growth of K562

368

Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients

369

Antitumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats

370

Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2′,2′-difluorodeoxycytidine on human hepatoma HepG2 cells

371

Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma

372

Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation

373

Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice

374

Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models

375

Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mammary cancer mediated by retrovirus

376

Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters

377

Antitumor effects of a polypeptide isolated from Tegillarca granosa linnaeus and the related molecular mechanism

378

Antitumor effects of a purified polysaccharide from Rhodiola rosea and its action mechanism

379

Antitumor effects of bis(ethyl)polyamine analogs on mammary tumor development in FVB/NTgN (MMTVneu) transgenic mice

380

Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line

381

Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells

382

Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression

383

Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells

384

Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts model

385

Anti-tumor Effects of Essential Oils of Red Clover and Ragweed on MCF-7 Breast Cancer Cell Line

386

Antitumor Effects of Ethanolic Extracts from Sophora moorcroftiana Seeds in Mice

387

Antitumor effects of flaxseed in Iranian traditional medicine and contemporary medicine; a brief review

388

Anti-tumor effects of fusion vaccine prepared by renal cell carcinoma 786-O cell line and peripheral blood dendritic cells of healthy volunteers in vitro and in human immune reconstituted SCID mice

389

Antitumor Effects of HPV DNA Vaccine Adjuvanted with Beclin-1 as an Autophagy Inducer in a Mice Model

390

Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma

391

Antitumor effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga

392

Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma

393

Anti-tumor effects of PEGylated-nanoliposomes containing ginger extract in colorectal cancer-bearing mice

394

Anti-tumor Effects of Recombinant Clostridium α-Toxin on Breast Cancer: An In Vitro and In Vivo Study

395

Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

396

Anti-Tumor Effects of the Methanol Extract of Ecballium elaterium (L.) A. Rich Fruits on Human Gastric (MKN-45) and Breast (MCF-7) Cancer Cell Lines

397

Antitumor Effects of Umbelliprenin in a Mouse Model of Colorectal Cancer

398

Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR

399

Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine

400

Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells

401

Antitumor efficacy of poly(brassylic acid–pentadecandioic acid) copolymer

402

Anti-tumor efficacy of polymer–platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice

403

Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors

404

Anti-tumor efficacy of ultrasonic cavitation is potentiated by concurrent delivery of anti-angiogenic drug in colon cancer

405

Antitumor Efficiency of Electrochemotherapy by High and Low Frequencies and Repetitive Therapy in the Treatment of Invasive Ductal Carcinoma in Balb/c Mice

406

Antitumor enhancement by adoptive transfer of tumor antigen primed, inactivated MHC-haploidentical lymphocytes

407

Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses

408

Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

409

Anti-tumor Immunity against CT26 Colon Tumor in Mice Immunized with Plasmid DNA Encoding β-Galactosidase Fused to an Envelope Protein of Endogenous Retrovirus

410

Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells

411

Anti-tumor immunity generated by tumor cells engineered to express B7-1 via retroviral or adenoviral gene transfer

412

Antitumor Immunity Induced by Genetic Immunization with Chitosan Nanoparticle Formulated Adjuvanted for HPV-16 E7 DNA Vaccine

413

Anti-tumor immunity: Myeloid leukocytes control the immune landscape

414

Antitumor mechanisms of 3′-ethynyluridine and 3′-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3′-ethynyluridine- resistant cells

415

Antitumor metastasis activity of pectic polysaccharide purified from the peels of Korean Citrus Hallabong

416

Anti-Tumor Necrosis Factor Alpha for Retinal Diseases: Current Knowledge and Future Concepts

417

Anti–Tumor Necrosis Factor-Alph Improves Myocardial Recovery After Ischemi and Reperfusion

418

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis

419

Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

420

Anti-tumor potential and acute toxicity of Jacaranda puberula Cham.(Bignoniacea)

421

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans

422

Antitumor promoting activities of 3-O-acyl-(−)-epigallocatechins

423

Anti-tumor promoting activity of Asteracantha longifolia against experimental hepatocarcinogenesis in rats

424

Anti-tumor promoting activity of Dryopteris phlorophenone derivatives

425

Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima

426

Anti-tumor Promoting Diterpenes from the Stem Bark of Thuja standishii (Cupressaceae) Original Research Article

427

Anti-tumor promoting effects of multiflorane-type triterpenoids and cytotoxic activity of karounidiol against human cancer cell lines

428

Anti-tumor promoting effects of naphthoquinone derivatives on short term Epstein-Barr early antigen activation assay and in mouse skin carcinogenesis

429

Anti-tumor promoting effects of palmitoyl: protein thioesterase inhibitors against a human neurotumor cell line

430

Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review

431

Antitumor properties of a heteroglucan isolated from Astraeus hygrometricus on Dalton’s lymphoma bearing mouse

432

Antitumor properties of Boswellic acid against Ehrlich ascites cells bearing mouse

433

Anti-tumor properties of orally administered glucosamine and N-acetyl-d-glucosamine oligomers in a mouse model

434

Antitumor properties of two traditional aromatic rice genotypes (Kalijira and Chinigura)

435

Antitumor response of CD14+/CD16+ monocyte subpopulation

436

Antitumor Response to a Codon-Optimized HPV-16 E7/HSP70 Fusion Antigen DNA Vaccine

437

Antitumor structure–activity relationship in bis-stannoxane derivatives from pyridine dicarboxylic and benzoic acids

438

Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents Original Research Article

439

Antitumor studies. Part 3: Design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins Original Research Article

440

Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs Original Research Article

441

Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins Original Research Article

442

Antitumor Synthetic Lipid A Analog DT-5461a Upregulates Cytokine Expression in a Murine Macrophage Cell Line through LPS Pathway

443

Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials

444

Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP)

445

Antitumoral effects of bisphosphonates on a UMR106 rat osteosarcoma spheroids

446

Antitumoral Effects of Digoxin in The Liver Cancer Cell Line is mediated through Induction of Apoptosis and Down Regulation of HIF-Α Expression

447

Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotein-producing human liver cancer cells

448

Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice

449

Antitumorigenic Effect of Cannabidiol in Lung Cancer: What Do We Know So Far?–A Mini Review

450

Anti-tumor-initiating effects of phenolic compounds isolated from the bark of Picea jezoensis var. jezoensis Original Research Article

451

Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa

452

Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein–Barr virus activation assay

453

Antitumor-promoting effects of cyclic diarylheptanoids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

454

Anti-tumor-promoting effects of glycoglycerolipid analogues on two-stage mouse skin carcinogenesis

455

Anti-tumor-promoting effects of isoflavonoids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

456

Anti-tumor-promoting effects of phenylpropanoids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

457

Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis

458

Antitumour Activity of Hibiscus tiliaceus Linn. Roots

459

Anti-tumour activity of plant flavonoids

460

Antitumour activity of protein A in a mouse skin model of two-stage carcinogenesis

461

Antitumour activity of sphingoid base adducts of phenethyl isothiocyanate

462

Anti-tumour activity of zoledronic acid

463

Anti-tumour and antioxidant activity of natural curcuminoids

464

Antitumour and antioxidant potential of some selected Pakistani honeys

465

Antitumour benzothiazoles. Part 10: The synthesis and antitumour activity of benzothiazole substituted quinol derivatives

466

Antitumour Benzothiazoles. Part 15:[] The Synthesis and Physico-Chemical Properties of 2-(4-Aminophenyl)benzothiazole Sulfamate Salt Derivatives

467

Antitumour benzothiazoles. Part 20: 3′-Cyano and 3′-Alkynyl-Substituted 2-(4′-Aminophenyl)benzothiazoles as new potent and selective analogues

468

Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis

469

Antitumour promoting activity of indole-3-carbinol in mouse skin carcinogenesis

470

Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones (‘quinols’)

471

Antitumour properties of the leaf essential oil of Xylopia frutescens Aubl. (Annonaceae)

472

Anti-tumour therapy in paraneoplastic neurological disease

473

Antitumour tiazofurin analogues embedded with an amide moiety at the C-2′ position

474

ANTITUMOUR-PROMOTING AND CYTOTOXIC CONSTITUENTS OF ETLINGERA ELATIOR

475

Antitussive activity of an extracellular Rhodella grisea proteoglycan on the mechanically induced cough reflex

476

Antitussive Effect of Plantago lanceolata in Guinea Pigs

477

Antitussive effect of Portulaca oleracea L. in guinea pigs

478

Antitussive effect of Portulaca oleracea L. in guinea pigs

479

Antitussive Effect of Rosa damascena in Guinea pigs

480

Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand

481

Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis

482

Antityrosinase and antimicrobial activities of 2-phenylethanol, 2-phenylacetaldehyde and 2-phenylacetic acid

483

Antityrosinase Inhibitory Activity of Phytochemicals from Alpinia aquatica Roscoe

484

ANTIULCER ACTIVITY OF ALLIUM SATIVUM BULB JUICE IN RATS

485

ANTIULCER ACTIVITY OF ALLIUM SATIVUM BULB JUICE IN RATS

486

ANTIULCER ACTIVITY OF CRUDE ALCOHOLIC EXTRACTS OF BOUGAINVILLEA SPECTABILIS WILLD

487

ANTIULCER ACTIVITY OF CRUDE ALCOHOLIC EXTRACTS OF BOUGAINVILLEA SPECTABILIS WILLD

488

Anti-ulcer activity of Smithia conferta in various animal

489

ANTIULCER AND ANTICONVULSANT ACTIVITY OF CROTON ZAMBESICUS

490

Anti-ulcer and Anti-inflammatory Effects of Hydroalcohol Extract of Aloe buettneri A. Berger (Lilliaceae)

491

Anti-Ulcer and anti-secretory Properties of the Butea Monosperma (Lam) Bark Extract with Relation to anti-oxidant Studies

492

Anti-ulcer effect of Tripleurospermum disciforme (C.A. Mey) Shultz Bip on pylorus ligated (Shay) rats

493

Anti-ulcer effects of cumin (Cuminum cyminum L.), thyme (Thymus vulgaris L.), and caraway (Carum carvi L.) essential oils on peptic ulcer and ulcerative colitis models in rats

494

Antiulcer effects of Zataria multiflora Boiss. on indomethacin-induced gastric ulcer in rats

495

Antiulcer Properties of Glycyrrhiza Glabra L. Extract on Experimental Models of Gastric Ulcer in Mice

496

Antiulcerative properties of crude polyphenols and juice of apple, and Chinese quince extracts

497

Antiulcerogenic Activity of Ethanolic Leaf Extract of Croton zambesicus in Rats

498

Antiulcerogenic Activity of Ethanolic Leaf Extract of Croton Zambesicus Muell. Arg

499

Antiulcerogenic Activity of methanol extract and solvent fractions of Stem Bark of Lannea acida (A. Rich) Against Ethanol-Induced Gastric Mucosal Injury in Albino Rats

500

Anti-ulcerogenic effect of ginger (rhizome of Zingiber officinale Roscoe) hydroalcoholic extract on acetic acid-induced acute colitis in rats

501

ANTI-ULCEROGENIC EFFECT OF GINGER (rhizome of Zingiber officinale Roscoe) ON YSTEMINE INDUCED DUODENAL ULCER IN RATS

502

Antiulcerogenic Effect of Zataria multiflora Boiss. on Cysteamine Induced Duodenal Ulcer in Rats

503

Antiulcerogenic Effects of Kolaviron: Inhibition of Apoptosis induced by Indomethacin in the intact Rat Stomach and Rat Gastric Mucosa Cell line

504

Antiulcerogenic Effects of Matricaria Chamomilla Extract in Experimental Gastric Ulcer in Mice.

505

Anti-urinary tract infection activity of selected herbal extract towards isolated Kosakonia cowanii (OQ 073698)

506

Antiurolithiatic Activity of Gokhsuradi Churan, an Ayurvedic Formulation By In Vitro Method

507

Antiurolithiatic Activity of Pinus Eldarica Medw. Fruits Aqueous Extract in Rats

508

Anti-Urolithiatic and Anti-Oxidant Effects of Fenugreek on Ethylene Glycol-Induced Kidney Calculi in Rats

509

Anti-Urolithiatic Effect of Ethanolic Extract of Pedalium Murex Linn. Fruits on Ethylene Glycol-Induced Renal Calculi

510

Anti-Urolithiatic Terpenoid Compound from Plantago major Linn. (Ekor Anjing)

511

Anti-vaccination movements and their interpretations

512

Antivacular Endothelial Growth Factor Agent and Their Development: Therapeutic Implication in Ocular Dieae Original Reearch Article

513

Anti-varicella Zoster Virus IgG and hsCRP Levels Correlate with Progression of Coronary Artery Atherosclerosis

514

Antivascular Endothelial Growth Factor-A Treatment: New Perspectives for High-Risk Plaque Stabilization

515

Anti-Vasculogenic Activity of a Polysaccharide Derived from Brittle Star via Inhibition of VEGF, Paxillin and MMP-9

516

Anti-VEGF Agent in the Treatment of Neovacular Age-related Macular Degeneration: Applying Clinical Trial Reult to the Treatment of Everyday Patient Original Reearch Article

517

Anti-VEGF Agents and Glaucoma Filtering Surgery

518

Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach

519

Anti-VEGF Bevacizumab (Avatin®) for Radiation Optic Neuropathy

520

Anti-VEGFR2 protein accumulation under the influence of methyl jasmonate treatment in Brassica napus and Nicotiana benthamiana plants

521

Antivenom Efficacy in Neutralizing Histopathological Complications Following Latrodectus dahli Envenomation

522

Antivenom for scorpion sting

523

Antivenom for scorpion sting

524

Antivenom for scorpion sting

525

Antivenom injection time related effects of Hemiscorpius lepturus scorpion envenomation in rabbits

526

Antivibration Electrode Support for Shipboard Stripping Voltammetry

527

Antivibration Electrode Support for Shipboard Stripping Voltammetry

528

Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: From anti-pestivirus to anti-hepatitis C virus activity

529

Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: Further optimization of anti-hepatitis C virus activity

530

Antiviral 6-amino-quinolones: Molecular basis for potency and selectivity

531

Antiviral activities against herpes simplex virus type 1 by HPH derivatives and their structure–activity relationships

532

Antiviral activities of coffee extracts in vitro

533

Antiviral activity and cytotoxicity of the lipophilic extracts of various edible plants and their fatty acids

534

Antiviral activity of alginate against infection by tobacco mosaic virus

535

Antiviral Activity of Alhagi maurorum Medik’s Methanolic Extract on Foot and Mouth Disease Virus (FMDV) in Cell Cultures

536

Antiviral activity of aqueous extract of alligator plant, Bryophyllum daigremontianum L., against RNA and DNA plant viruses

537

Antiviral Activity of Arnebia Euchroma and Amniotic Membrane against HSV-1, Rotavirus, and Influenza Virus

538

Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives Original Research Article

539

Antiviral Activity of Benzotriazole Based Derivatives

540

Antiviral activity of berberine and related compounds against human cytomegalovirus

541

Antiviral activity of biosynthesized copper nanoparticle by Juglans regia green husk aqueous extract and Iron nanoparticle: molecular docking and in-vitro studies

542

Antiviral activity of bis(2-methylheptyl)phthalate isolated from Pongamia pinnata leaves against White Spot Syndrome Virus of Penaeus monodon Fabricius

543

Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (Smallpox, monkeypox and cowpox)

544

Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro

545

Anti-viral activity of galectin-1 from flounder Paralichthys olivaceus

546

Antiviral activity of garlic extract on Influenza virus

547

Antiviral activity of isoindole derivatives

548

Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro.

549

Antiviral activity of Mx proteins from gilthead seabream (Sparus aurata) against lymphocystis disease virus (LCDV)

550

Antiviral activity of natural products extracted from marine organisms

551

Antiviral Activity of Obtained Extracts from Different Parts of Cupressus sempervirens against Herpes Simplex Virus Type 1

552

Antiviral Activity of Pomegranate (𝑃𝑢𝑛𝑖𝑐𝑎 𝑔𝑟𝑎𝑛𝑎𝑡𝑢𝑚) Extract Against DENV-3: 𝐼𝑛 𝑆𝑖𝑙𝑖𝑐𝑜 and 𝐼𝑛 𝑉𝑖𝑡𝑟𝑜 Study

553

Antiviral activity of tea tree and eucalyptus oil aerosol and vapour

554

Antiviral Activity of the Glucan Lichenan (Poly-β(→ 3,1 → 4)D-anhydroglucose). 2. Studies on the Mode of Action

555

Antiviral Activity of the Glucan Lichenan (Poly-β(l→3, 1→4)D-anhydroglucose). 1. Biological Activity in Tobacco Plants

556

Antiviral Activity of Thiazolide Derivatives Against Dengue Virus in Huh-7 Cell Line

557

Antiviral Activity of Three Plant Species, Rhus coriaria, Chenopodium quinoa, and Ailanthus altissima against Tobacco Mosaic Virus

558

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

559

antiviral and anti-inflammatory drugs to combat covid-19: effects on cardiac ion channels and risk of ventricular arrhythmias

560

Antiviral and antiproliferative effects of canine interferon-λ1

561

Antiviral and antiproliferative effects of canine interferon-λ1

562

Antiviral and Immunostimulant Activities of Andrographis paniculata

563

Antiviral and metabolic gene expression responses to viral infection in Atlantic salmon (Salmo salar)

564

Antiviral and tumor cell antiproliferative SAR studies on tetracyclic eudistomins—II Original Research Article

565

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients

566

Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease

567

Antiviral cyclic d,l-α-peptides: Targeting a general biochemical pathway in virus infections Original Research Article

568

Antiviral DNA vaccination in rainbow trout (Oncorhynchus mykiss) affects the immune response in the ovary and partially blocks its capacity to support viral replication in vitro

569

Antiviral drug design: computational analyses of the effects of the L100I mutation for HIV-RT on the binding of NNRTIs

570

Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell Populations

571

Antiviral drugs: unapproved uses, dosages, or indications

572

Anti-viral Effect and Mechanism of Carvacrol on Herpes Simplex Virus Type 1

573

Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model

574

Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus Original Research Article

575

Antiviral effect of recombinant equine interferon-γ on several equine viruses

576

Antiviral effect of recombinant equine interferon-γ on several equine viruses

577

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen

578

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

579

Antiviral Effects of Aloe vera (L.) Burm.f. and Ruta Graveolens L. Extract on Acyclovir-Resistant Herpes Simplex Virus Type 1

580

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

581

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

582

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

583

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

584

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

585

Antiviral effects of bovine IFN-τ and human IFN-α on bovine viral diarrhea virus

586

Antiviral effects of cranberry juice and cranberry proanthocyanidins on foodborne viral surrogates – A time dependence study in vitro Original Research Article

587

Anti-viral effects of interferon administration on sevenband grouper, Epinephelus septemfasciatus

588

Antiviral Effects of Olea europaea Leaves Extract and Interferon-beta on Gene Expression of Newcastle Disease Virus

589

Antiviral effects of β-defensin derived from orange-spotted grouper (Epinephelus coioides)

590

Anti-Viral Evaluation of Sesquiterpene Coumarins from Ferula assa-foetida against HSV-1

591

Antiviral function of tilapia hepcidin 1–5 and its modulation of immune-related gene expressions against infectious pancreatic necrosis virus (IPNV) in Chinook salmon embryo (CHSE)-214 cells

592

Anti-viral gene induction is absent upon secondary challenge with double-stranded RNA in the Pacific oyster, Crassostrea gigas

593

Antiviral hepatitis and antiretroviral drug interactions

594

Antiviral Immune Responses of Mice Lacking MHC Class II or Its Associated Invariant Chain

595

Antiviral Immunity Directed by Small RNAs

596

Antiviral immunity in crustaceans

597

Antiviral Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Dyndrome: A Literature Review

598

Antiviral Inhibition of the HIV-1 Capsid Protein

599

Antiviral Innate Immunity: Editorial Overview

600

Anti-viral mechanism of barramundi Mx against betanodavirus involves the inhibition of viral RNA synthesis through the interference of RdRp

601

Antiviral Mechanisms of Human Defensins Review Article

602

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials

603

Antiviral potentials of medicinal plants

604

Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus

605

Antiviral properties of cobalt(III)-complexes Original Research Article

606

Antiviral resistance and the control of pandemic influenza: The roles of stochasticity, evolution and model details

607

Antiviral T-cell responses and therapy in chronic hepatitis B

608

Antiviral therapies for hepatitis-related glomerulonephritis

609

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma

610

Antiviral Therapy in Management of COVID-19: a Systematic Review on Current Evidence

611

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation

612

Antiviral treatment after solid organ transplantation

613

Antiviral treatment after solid organ transplantation – Authorsʹ reply

614

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination,

615

Antiviral Vector Effects of Ivermectin on COVID-19: An updat‎e

616

Antivirals for influenza in healthy adults

617

Antivirals for influenza in healthy adults

618

Antivirals for influenza in healthy adults

619

Antivirals for influenza in healthy adults – Authorsʹ reply

620

Antivirals for influenza in healthy adults: systematic review

621

Antiviroid activity of chitosan

622

Anti-virulence potential of eugenol-rich fraction of Syzygium aromaticum against multidrug resistant uropathogens isolated from catheterized patients

623

Anti-virulence Therapy Against Bacterial Infections: Mechanisms of Action and Challenges

624

Antiviruses as Therapeutic Agents: A Mathematical Analysis of Their Potential

625

Anti-visceral obesity and antioxidant effects of powdered sea buckthorn (Hippophae rhamnoides L.) leaf tea in diet-induced obese mice

626

Antiwar Groups in the United States: A Case of the Opposition to War against Iran after the September 11th

627

Anti-wear multilayer coatings based on chromium nitride for wood machining tools

628

Antiwear performance of polysiloxane-containing copolymers at oil/metal interface under extreme pressure

629

Antiwear properties of carbon-coated copper nanoparticles used as an additive to a polyalphaolefin

630

Anti-wear properties of the molluscan shell Scapharca subcrenata: Influence of surface morphology, structure and organic material on the elementary wear process

631

Anti-wetting Cu/Cr coating with micro-posts array structure fabricated by electrochemical approaches

632

Anti-windup and bumpless-transfer schemes

633

Anti-windup compensator for active queue management in TCP networks

634

Anti-windup control design for exponentially unstable LTI systems with actuator saturation

635

Anti-windup design for saturating quadratic systems

636

Antiwindup design for the speed loop PI controller of a PMSM servo system

637

Anti-windup design of output tracking systems subject to actuator saturation and constant disturbances

638

Antiwindup design with guaranteed regions of stability: an LMI-based approach

639

Anti-Windup Designs for Multivariable Controllers

640

anti-windup for linear dead-time systems

641

Antiwindup for stable linear systems with input saturation: an LMI-based synthesis

642

Anti-windup schemes for uncertain nonlinear systems

643

Anti-windup synthesis for linear control systems with input saturation: Achieving regional, nonlinear performance

644

Anti-windup synthesis via sampled-data piecewise affine optimal control

645

Anti-windup via constrained regulation with observers

646

Anti-Wolbachia treatment for lymphatic filariasis

647

Anti-xanthine oxidase antibodies in sera and synovial fluid of patients with rheumatoid arthritis and other joint inflammations

648

Antixenosis resistance of one-year-old poplar seedlings of different clones to poplar clearwing moth, Paranthrene tabaniformis Rott. (Lep.: Sessiidae)

649

Antixenotic resistance of eight Cucumis genotypes to melon aphid Aphis gossypii (Hemiptera: Aphididae) and some associated plant traits

650

Anti-yeast activity of mentha oil and vapours through in vitro and in vivo (real fruit juices) assays

651

Anti-Yo Mediated Paraneoplastic CerebellarDegeneration Associated with Pseudobulbar Affectin a Patient with Breast Cancer

652

Anti-zona pellucida antibodies in infertile patients in relation to multiple puncture of ovaries and unexplained infertility

653

Anti-α-enolae antibodie in cancer-aociated retinopathy with mall cell carcinoma of the lung

654

Anti-α-glucosidase activity of Chinese traditionally fermented soybean (douchi)

655

Anti-β1-adrenoceptor autoantibodies increase L-type Ca2+ current in human atrial myocytes

656

Anti-β2 Glycoprotein 1 and the Anti-phopholipid yndrome

657

Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome

658

Anti–β2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome, ,

659

Anti-β2-glycoprotein-I antibodies in scFv format

660

Anti-βs-Ribozyme Reduces βs mRNA Levels in Transgenic Mice: Potential Application to the Gene Therapy of Sickle Cell Anemia

661

Antley-Bixler Syndrome: Surgical Management of Ambiguous Genitalia – A Case Report

662

Antlion Optimization Algorithm for Optimal Self-Scheduling Unit Commitment in Power System Under Uncertainties

663

Antlions (Insecta: Neuroptera: Myrmeleontidae) of Albania

664

Ant-mediated effects on spruce litter decomposition, solution chemistry, and microbial activity

665

Ant-mediated effects on spruce litter decomposition, solution chemistry, and microbial activity

666

Ant-nest ichnofossils in honeycomb calcretes, Neogene Ogallala Formation, High Plains region of western Kansas, U.S.A.

667

Anton P. Chekhov, MD (1860–1904): Dual medical and literary careers

668

Antoni Zygmund and His Work

669

Antonio (Ninni) DʹAlessio (1943–2008)

670

Antonio Argandona and Jordi Gual, Editors, The Social Dimensions of Employment: Institutional Reforms in Labour Markets, Edward Elgar, Cheltenham, UK (2002) xv+ 154 pp..

671

Antonio Becchi, Massimo Corradi, Frederico Foce and Orietta Pedemonte, Editors, Essays on the History of Mechanics: In Memory of Clifford Ambrose Truesdell and Edoardo Benvenuto, Birkhäuser Verlag, Boston/Basel (2003) ISBN 3764314761 256 pp..

672

Antonio Berti, Giovanni Brugnoli and the First Studies on Aphasia in Italy

673

Antonio F. Corno MD , Congenital Heart Defects. Decision Making for Cardiac Surgery, Volume 1: Common Defects, Steinkopff-Verlag Darmstadt, Germany (2003) 159 pp, illustrated, $129.00 ISBN: 3-7985-1415-1.

674

Antonio Genovesiʹs Diceosina: Source of the Neapolitan enlightenment

675

Antonio Scarpa was an outstanding “head” in the history of surgery

676

Antonio Vallisnieri - Ein moderner Geologe vor 300 Jahren

677

Antonyms and linguistic quantifiers in fuzzy logic

678

Antonymy and negation—The boundedness hypothesis

679

Antonymy in Persian Language: a Cognitive Approach

680

AntP2PR: An ant intelligence inspired routing scheme for Peer-to-Peer networks

681

Antral contractility following Asian-style meal in healthy volunteers: effect of genders, menstruation, smoking status and age.

682

Antral follicie counts by transvaginal ultrasonography are related to age in women with proven natural fertility

683

Antral follicle growth and endocrine changes in prepubertal cattle, sheep and goats

684

Antral follicle growth and endocrine changes in prepubertal cattle, sheep and goats

685

Antral follicles develop in xenografted cryopreserved african elephant (Loxodonta africana) ovarian tissue

686

Antral Follicular Count, Ovarian Volume and Anti-mullerian Hormone in the Prediction of Cycle Cancellation and Poor Response in Women Undergoing Controlled Ovarian Stimulation

687

Antrasiklin ile tedavi edilen yaşayan asemptomatik çocuklarda uzun dönemde gelişebilecek kardiyotoksisitenin erken tanısında dobutamin stres ekokardiyografinin yeri

688

Antrenör Eğitim Sistemi Açısından 30978 Sayılı Antrenör Eğitimi Yönetmeliği’nin Değerlendirilmesi

689

Antrochoanal polyp mimicking juvenile nasoangiofibroma

690

Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo

691

Antrodia camphorata suppresses lipopolysaccharide-induced nuclear factor-κB activation in transgenic mice evaluated by bioluminescence imaging

692

Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor κB pathway

693

Antrodia cinnamomea profoundly exalted the reversion of activated hepatic stellate cells by the alteration of cellular proteins

694

Antrodia salmonea in submerged culture exhibits antioxidant activities in vitro and protects human erythrocytes and low-density lipoproteins from oxidative modification

695

Antrolith in the Maxillary Sinus; Report of a Case

696

Antro-pancreatic reflexes: long- and short-route reflexes in exocrine and endocrine pancreatic secretion in dogs

697

ANTROPOLOJİNİN AKRABALIK YAKLAŞIMLARI

698

Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells

699

Ants (Hymenoptera: Formicidae) diversity in agricultural ecosystems at Mezquital Valley, Hidalgo, Mexico

700

Ants and frogs round a pond: interpretations of Mediterranean historical geography

701

Ants and plants – a world of interactions

702

Ants as bioindicators of soil function in rural environments

703

Ants can solve the team orienteering problem

704

Ants for track initiation of bearings-only tracking

705

Ants have a negative rather than a positive effect on extrafloral nectaried Crotalaria pallida performance

706

707

Ants in Tropical Urban Habitats: The Myrmecofauna in a Densely Populated Area of Bogor, West Java, Indonesia

708

Ants move to improve: colonies of Leptothorax albipennis emigrate whenever they find a superior nest site

709

Ants of the genus CamponotusMayr, 1861 (Hymenoptera: Formicidae) in the Kaz Mountains, Turkey, with descriptions of sexuals of Camponotus candiotes Emery, 1894 and Camponotus ionius Emery, 1920

710

Ants ordering ants to feed

711

Ants use odour cues to exploit fig–fig wasp interactions

712

Ants with three primary colors for track initiation

713

Ant–seed mutualisms: can red imported fire ants sour the relationship? Original Research Article

714

AntStar: Enhancing Optimization Problems by Integrating an Ant System and Algorithm

715

A-Numerical Radius and Product of Semi-Hilbertian Operators

716

A-Numerical Radius Orthogonality and Parallelism of Semi-Hilbertian Space Operators and Their Applications

717

AnumericalstudyofradiationheattransferinsodiumpoolcombustionandresponsesurfacemodelingofluminousflameemissivityOriginalResearchArticle

718

719

Anuran species richness, complementarity and conservation conflicts in Brazilian Cerrado

720

Anurans from the Candeleros Formation (?Cenomanian-Turonian) of west-central Argentina: new evidence for pipoid evolution

721

Anurans from the Early Cretaceous Lagerstنtte of Las Hoyas, Spain: New evidence on the Mesozoic diversification of crown-clade Anura

722

Anurans from the Lower Cretaceous Crato Formation of northeastern Brazil: implications for the early divergence of neobatrachians

723

Anuria and Hydronephrosis due to Ureteropelvic Junction Obstruction: A Case Report

724

Anuria due to acute bilateral renal vein occlusion after thrombolysis for pulmonary embolism

725

Anuria in solitary kidney patient with gastroenteritis: A case report study

726

Anwendung nichtlinearer Wachstumsfunktionen und aus ihnen abgeleitete relevante GroBen

727

ANXA2, PRKCE, and OXT are critical differentially genes in nonalcoholic fatty liver disease

728

Anxiété, anxiolytiques et troubles cognitifs

729

Anxiété, dépression et expérience quotidienne du stressAnxiety, depression and daily stress experience

730

Anxieties in Mainland Chinese and Singapore Chinese adolescents in comparison with the American norm

731

Anxiety about environmental hazards among teenagers in Helsinki, Moscow and Tallinn

732

Anxiety among Adults with Diabetes in Fasa Diabetes Registry System: Risk Factors and Relationship to Blood Sugar Control

733

Anxiety and affective style: role of prefrontal cortex and amygdala

734

Anxiety and anger effects on depressed mother–infant spontaneous and imitative interactions

735

Anxiety and arousal: physiological changes and their perception

736

Anxiety and athletic performance of finnish athletes: Application of the zone of optimal functioning model

737

Anxiety and attentional focusing: trait, state and hemispheric influences

738

Anxiety and Coping Strategies During the COVID-19 Pandemic in Mothers of Children with Thalassemia

739

Anxiety and coping strategies in people who stutter

740

Anxiety and Coping Style between Successful Pregnancy and Non-Successful Pregnancy Regarding Recurrent Abortion

741

Anxiety and coping with community disasters: The Israeli experience

742

Anxiety and counter-conditioning: the role of the behavioral inhibition system in the ability to associate aversive stimuli with future rewards

743

Anxiety and defensiveness: individual differences in affective startle modulation

744

Anxiety and depression 3 years following stroke: Demographic, clinical, and psychological predictors

745

Anxiety and depression after acute myocardial infarction

746

Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age

747

Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?

748

ANXIETY AND DEPRESSION AMONG ASTHMATIC PATIENTS IN MALAYSIA

749

Anxiety and depression among hiv-infected heterosexuals— a report from india

750

Anxiety and depression among medical students: A cross-sectional study

751

Anxiety and Depression among Tertiary Level Students in Bangladesh during COVID-19 Outbreak

752

Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease

753

Anxiety and depression are separate psychiatric conditions that are often interrelated. This study examines whether they exist independently in this population of patients with partial epilepsy and if they affect all quality-of-life domains. Adult epileps

754

Anxiety and depression as correlates of self-reported behavioural inhibition in normal adolescents

755

Anxiety and Depression as Predictors of Cardiovascular Outcomes After Cardiac Surgery

756

Anxiety and depression as risk factors for mortality after coronary artery bypass surgery

757

Anxiety and depression disorders 5 years after severe injuries: A prospective follow-up study

758

Anxiety and depression during pregnancy in women and men

759

Anxiety and depression following myocardial infarction: gender differences in a 5-year prospective study

760

Anxiety and Depression Following Traumatic Brain Injury

761

Anxiety and depression in a post-September 11 sample of Arabs in the USA

762

Anxiety and Depression in a Sample of Iranian Patients With Irritable Bowel Syndrome

763

Anxiety and depression in bariatric surgery patients: A prospective, follow-up study using structured clinical interviews

764

Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire

765

Anxiety and depression in children with epilepsy and their mothers

766

Anxiety and Depression in Children with HFASDs: Symptom Levels and Source Differences

767

Anxiety and depression in Chinese patients with glaucoma: Sociodemographic, clinical, and self-reported correlates

768

Anxiety and depression in chronic obstructive pulmonary disease: A new intervention and case report Original Research Article

769

Anxiety and Depression in Female Patients with Breast Cancer: A Study of Predictors

770

Anxiety and depression in juvenile diabetes: A critical review

771

ANXIETY AND DEPRESSION IN MOTHERS OF DISABLED AND NON-DISABLED CHILDREN

772

ANXIETY AND DEPRESSION IN NURSES WORKING IN GOVERNMENT TERTIARY CARE TEACHING HOSPITALS OF PESHAWAR KHYBER PAKHTUNKHWA AND THEIR RELATIONSHIP WITH JOB STRESS

773

Anxiety and Depression in Patients Attending Institute of Dentistry CMH Lahore

774

Anxiety and Depression in Patients Undergoing Coronary Angioplasty

775

Anxiety and Depression in Patients with Amputated Limbs Suffering from Phantom Pain: A Comparative Study with Non-Phantom Chronic Pain

776

Anxiety and depression in patients with chronic temporomandibular pain and in controls

777

Anxiety and depression in patients with chronic temporomandibular pain and in controls

778

Anxiety and Depression in Patients with Coronary Heart Disease: A Study in a Tertiary Hospital

779

Anxiety and depression in patients with prostate cancer and other urogenital cancer: A longitudinal study

780

Anxiety and depression in pre-and-post-hematopoietic stem cell transplants in SCT center, Shariati Hospital, Tehran, Iran

781

Anxiety and depression in primary care patients: Predictors of symptom severity and developmental correlates

782

Anxiety and depression in the working population using the HAD Scale

783

Anxiety and depression in the workplace: Effects on the individual and organisation (a focus group investigation)

784

Anxiety and depression predicted by medically unexplained symptoms in Pakistani children: A case-control study

785

Anxiety and depression symptoms in adolescents suffering from various chronic diseases

786

Anxiety and depression symptoms in women and men from early pregnancy to 3-months postpartum: Parity differences and effects

787

Anxiety and depression, chronic physical conditions, and quality of life in an urban population sample study

788

Anxiety and Depression: A Comparison between Living and Cadaveric Renal Transplant Recipients

789

Anxiety and depression: Incidence and patterns in patients after coronary artery bypass graft surgery

790

Anxiety and depression: Why and how to measure their separate effects

791

Anxiety and Depressive Symptomatology among Iranian Patients Hospitalized for COVID-19 in January 2020

792

Anxiety and Depressive Symptoms among Ischaemic Heart Disease Patients in a Malaysian Tertiary University Hospital

793

Anxiety and Depressive Symptoms and Coping Strategies in Nasopharyngeal Carcinoma Patients in Hospital Kuala Lumpur

794

Anxiety And Depressive Symptoms And Health-Related Quality Of Life Status Among Patients With Cancer In Terengganu, Malaysia

795

Anxiety and depressive symptoms related to parenthood in a large Norwegian community sample: the HUNT2 study

796

Anxiety and error monitoring: Increased error sensitivity or altered expectations?

797

Anxiety and explicit alcohol-related memory in problem drinkers

798

Anxiety and extraction of third molars in Turkish patients

799

Anxiety and health-related quality of life in patients awaiting elective coronary angiography

800

Anxiety and Hostility in the Manifest Dreams of Schizophrenic Patients.

801

Anxiety and impulsivity levels identify relevant subtypes in adolescents with at-risk behavior

802

Anxiety and irritable bowel syndrome

803

Anxiety and its disorders: The nature and treatment of anxiety and panic

804

Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic, 2nd Edition, D.H. Barlow. The Guilford Press, New York (2002)

805

Anxiety and judgements about emotional events in children and adolescents

806

Anxiety and logos: Toward a linguistic analysis of the origins of human thinking

807

Anxiety and memory: A recall bias for threatening words in high anxiety

808

Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology

809

Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphisms

810

Anxiety and Obsession Following the COVID-19 Outbreak

811

Anxiety and pain during dental injections

812

Anxiety and pain during dental injections

813

Anxiety and patient participation in clinical decision-making: The case of patients with ureteral calculi

814

ANXIETY AND PERFORMANCE: AN ENDOGENOUS LEARNING-BY-DOING MODEL∗

815

Anxiety and Persistence of Lyme Disease

816

Anxiety and phobic disorders: A pragmatic approach : Wendy K. Silverman and William M. Kurtines. New York: Plenum Press, 1996. 142 pp. Hardcover: $35.00, Softcover, $19.50

817

Anxiety and postoperative pain in children who undergo major orthopedic surgery

818

Anxiety and post-traumatic stress symptoms following wisdom tooth removal

819

Anxiety and risk for substance dependence among late adolescents/young adults

820

Anxiety and Risk of Incident Coronary Heart Disease: A Meta-Analysis

821

Anxiety and risk of type 2 diabetes: Evidence from the Baltimore Epidemiologic Catchment Area Study

822

Anxiety and risky decision-making: The role of subjective probability and subjective costs of negative events

823

Anxiety and selective attention in obsessive–compulsive disorder

824

Anxiety and Selfcare Behavior in Patients Undergoing Head and Neck Radiotherapy: Effect of Print and Multimedia Health Materials

825

Anxiety and Self-care Behavior in Patients Undergoing Head and Neck Radiotherapy: Effect of Print and Multimedia Health Materials

826

Anxiety and self-consciousness in patients with facial lacerations one week and six months later

827

Anxiety and Self-Esteem Score in Adults with a Suicide Attempt History

828

Anxiety and sensitivity to eye gaze in emotional faces

829

Anxiety and Social Phobia in Stuttering

830

Anxiety and Stress Seem Temporary during the Pneumonia COVID-19 Pandemic: A Survey on the Mental Health Status of Healthcare Workers

831

Anxiety and stress vulnerability and substance problems: Theory, empirical evidence, and directions for future research

832

Anxiety and subjective quality of life preoperatively and 4 months after reduction mammaplasty

833

Anxiety and substance use disorders: introduction to the special series

834

Anxiety and surgical recovery: Reinterpreting the literature

835

Anxiety and technological change — Explaining the inverted U-curve of sulphur dioxide emissions in late 20th century Finland

836

Anxiety and temporomandibular joint disorders among law students in Iran

837

Anxiety and the Interpretation of Ambiguous Information: Beyond the Emotion-Congruent Effect

838

Anxiety and Uterine Artery Doppler Flow in A Population of Pregnant Women of High Risk Down Syndrome Fetus: A Prospective Cohort Study

839

Anxiety and Writing Ability of Filipino ESL Learners

840

ANXIETY AS A DETERRING ELEMENT IN LEARNING ENGLISH FOR ORAL COMMUNICATION AMONG EFL STUDENTS

841

Anxiety as a Predictor of Age at First Use of Substances and Progression to Substance Use Problems Among Boys

842

Anxiety assessment and Waist to hip ratio in medical students

843

Anxiety Assessment in Methamphetamine - Sensitized and Withdrawn Rats: Immediate and Delayed Effects

844

Anxiety Behavior, Exploratory Behavior, and Activity in NZB × NZW F1 Hybrid Mice: Role of Genotype and Autoimmune Disease Progression

845

Anxiety but not depression is associated with metabolic syndrome: The Isfahan Healthy Heart Program

846

Anxiety Characteristics Independently and Prospectively Predict Myocardial Infarction in Men: The Unique Contribution of Anxiety Among Psychologic Factors Original Research Article

847

Anxiety Control in the Dental Patient

848

Anxiety Control in the Iranian Children with Chronic Leukemia: Use of a Non-drug Method

849

ANXIETY DEPRESSION IN INFERTILE WOMEN

850

Anxiety Disorder Among Adolescents with Asthma in Zanjan

851

Anxiety disorder of 3-6 year-old children

852

Anxiety disorder specificity of anxiety sensitivity in a community sample of young women

853

Anxiety disorders

854

Anxiety Disorders — Psychological Approaches to Theory and Treatment Michelle G. Craske; Westview Press, Boulder, Colorado, 1999, xxi + 423 pp. Price £37.95

855

Anxiety disorders and control related beliefs: the exemplar of Obsessive–Compulsive Disorder (OCD)

856

Anxiety disorders and its risk factors among the Sichuan empty-nest older adults: A cross-sectional study

857

Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness

858

Anxiety Disorders and Quality of Life among Patients with Hematological Cancer in a Malaysian Hospital

859

Anxiety disorders and workplace-related anxieties

860

Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary

861

Anxiety Disorders Comorbidity in Iranian Patients with Mood Disorders and Itsʹ Relationship with Suicidal Attempt

862

Anxiety disorders comorbidity in mood disorder subgroups: data from a mood disorders clinic

863

Anxiety disorders due to motor vehicle accidents: Nature and treatment

864

Anxiety disorders in a public mental health system: Clinical characteristics and service use patterns

865

Anxiety disorders in adults: an evidence-based approach to psychological treatment: Peter D. Mclean & Sheila R. Woody; Oxford University Press, New York, 2001, pp. xvi + 369

866

Anxiety Disorders in Children with Functional Constipation: A Case-Control Study

867

Anxiety disorders in children: Family matters Original Research Article

868

Anxiety disorders in intimate partners and the quality of their relationship

869

Anxiety disorders in multiple sclerosis: significance of obsessive-compulsive disorder comorbidity

870

Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life

871

Anxiety disorders in parkinsonʹs disease: Insights into the neurobiology of neurosis

872

Anxiety Disorders in Pediatric Dentistry and Their Accordance with Parents’ Reports

873

Anxiety disorders in youth: Diagnostic consistency across DSM-III-R and DSM-IV

874

Anxiety during pregnancy and preeclampsia: a case- control study

875

Anxiety during the menopausal transition: A systematic review

876

Anxiety Effect: A Case of Text Modification and the Effect of High and Low Anxiety Levels on Medical Students’ Comprehension Performance

877

Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention

878

Anxiety following miscarriage and the subsequent pregnancy: A review of the literature and future directions

879

Anxiety goes under the skin: Behavioral inhibition, anxiety, and autonomic arousal in speech-anxious males

880

Anxiety in a neglected population: Prevalence of anxiety disorders in pre-adolescent children

881

Anxiety in children with epilepsy

882

Anxiety in Children with Mood Disorders: A Treatment Help or Hindrance?

883

Anxiety in dementia: A critical review

884

Anxiety in intergroup relations: a comparison of anxiety/uncertainty management theory and integrated threat theory

885

Anxiety in mice following acute aspartame and ethanol exposure

886

Anxiety in patients and its relation with patients’ psychospiritual behaviors

887

Anxiety in patients undergoing percutaneous coronary interventions

888

Anxiety in Patients with Chronic Cor Pulmonale and Its Effect on Exercise Capacity

889

Anxiety in Patients with Chronic Cor Pulmonale and Its Effect on Exercise Capacity

890

Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management

891

Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex.

892

Anxiety in pregnant and postpartum women. An exploratory study of the role of maternal orientations

893

Anxiety in quake-stricken children aged 3 to 7: A screening study in Sarpol- Zahab, Iran

894

Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study

895

Anxiety in speakers who persist and recover from stuttering

896

Anxiety in the eating disorders: Understanding the overlap

897

Anxiety in the Operating Room Before Elective Surgery

898

Anxiety in unipolar and bipolar depression

899

Anxiety level among nursing staff during the coronavirus disease 2019 pandemic: a cross-sectional study

900

Anxiety level of Iranian patients with psychiatric disorders and related factors: A cross-sectional study

901

Anxiety Level of Pregnant Women from Ahwaz Exposed to Domestic Violence

902

Anxiety Levels Among Female Iranian Health Care Workers During the COVID-19 Surge: A Cross-sectional Study

903

Anxiety levels in adolescents who stutter

904

Anxiety levels in EMS providers: Effects of violence and shift schedules

905

Anxiety levels of mothers with newborns in a Neonatal Intensive Care Unit in Turkey

906

Anxiety linked to a protein kinase enzyme

907

Anxiety Management in Adult Day Surgery, M. Mitchell. Whurr (2005), ISBN: 1-86156-463-5

908

Anxiety management: a distinct nursing role in day surgery

909

Anxiety measures and their relationship to adolescent suicidal ideation and behavior

910

Anxiety measures validated in perinatal populations: A systematic review

911

Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients

912

Anxiety of childhood and adolescence: Challenges and opportunities

913

Anxiety of dependency in international joint ventures? An empirical study of drivers and conseque nces of relationship insecurity

914

Anxiety of Women Employees and The Process of Maternal Role

915

Anxiety of young female athletes with disordered eating behaviors

916

Anxiety Profile in Children and Adolescents with Stuttering

917

Anxiety Rating for Children — Revised: Reliability and validity

918

Anxiety Reduction and RALL Implementation in English Grammar Acquisition among EFL Learners

919

Anxiety reduction program for some social phobics: A connection?

920

Anxiety responses to CO2 inhalation in subjects at high-risk for panic disorder

921

Anxiety Sensitivity Amelioration Training (ASAT): A longitudinal primary prevention program targeting cognitive vulnerability

922

Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation

923

Anxiety sensitivity among children of parents with anxiety disorders: a controlled high-risk study

924

Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder

925

Anxiety sensitivity and alcohol use motives

926

Anxiety sensitivity and auditory perception of heartbeat

927

Anxiety sensitivity and disgust sensitivity interact to predict contamination fears

928

Anxiety sensitivity and drug choice in individuals seeking treatment for substance abuse

929

Anxiety sensitivity and drug or alcohol use in individuals with anxiety and substance use disorders

930

Anxiety sensitivity and fear of pain in patients with recurring headaches

931

Anxiety sensitivity and impairment: Evidence for a direct association and partial mediation by subclinical anxiety symptoms

932

Anxiety sensitivity and intolerance of uncertainty: Requisites of the fundamental fears?

933

Anxiety sensitivity and its dimensions across the anxiety disorders

934

Anxiety sensitivity and major depression: examination of affective state dependence

935

Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension

936

Anxiety sensitivity and menstrual cycle reactivity: Psychophysiological and self-report differences

937

Anxiety sensitivity and modulation of the serotonergic system in patients with PD

938

Anxiety sensitivity and other emotionality traits in predicting headache medication use in patients with recurring headaches: Implications for abuse and dependency

939

Anxiety sensitivity and pain-related anxiety in the prediction of fear responding to bodily sensations: A laboratory test

940

Anxiety sensitivity and panic attack symptomatology among low-income African–American adolescents

941

Anxiety sensitivity and panic disorder

942

Anxiety sensitivity and panic disorder

943

Anxiety sensitivity and perceived control over anxiety-related events: Evaluating the singular and interactive effects in the prediction of anxious and fearful responding to bodily sensations

944

Anxiety sensitivity and posttraumatic stress among traumatic event-exposed youth

945

Anxiety Sensitivity and Response to Hyperventilation Challenge: Physiologic Arousal, Interoceptive Acuity, and Subjective Distress

946

Anxiety sensitivity and self-reported alcohol consumption rates in university women

947

Anxiety Sensitivity and Situation-Specific Drinking

948

Anxiety sensitivity and the five-factor model of personality

949

Anxiety sensitivity and the pathogenesis of anxiety and depression: evidence for symptom specificity

950

Anxiety sensitivity and the pathogenesis of anxiety and depression: evidence for symptom specificity

951

Anxiety sensitivity and worry

952

Anxiety sensitivity as a predictor of the development of panic symptoms, panic attacks, and panic disorder: a prospective study

953

Anxiety sensitivity cognitive concerns predict suicidality among smokers

954

Anxiety Sensitivity Dimensions and Generalized Anxiety‏ ‏Severity: The ‎Mediating Role of Experiential Avoidance and Repetitive‏ ‏Negative Thinking

955

Anxiety sensitivity in adolescents: factor structure and relationships to trait anxiety and symptoms of anxiety disorders and depression

956

Anxiety sensitivity in first-degree relatives of patients with panic disorder

957

Anxiety sensitivity in patients with physically unexplained chronic back pain: A preliminary report

958

Anxiety sensitivity in six countries

959

Anxiety sensitivity in the prediction of pain-related fear and anxiety in a heterogeneous chronic pain population

960

Anxiety sensitivity in traumatized Cambodian refugees: A discriminant function and factor analytic investigation

961

Anxiety Sensitivity Index: normative data and its differentiation from trait anxiety

962

Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users

963

Anxiety sensitivity mediates the relationships between childhood learning experiences and elevated hypochondriacal concerns in young adulthood

964

Anxiety sensitivity taxonicity across gender among youth

965

Anxiety sensitivity within the anxiety disorders: Disorder-specific sensitivities and depression comorbidity

966

Anxiety sensitivity, body vigilance and fear of pain

967

Anxiety sensitivity, conscious awareness and selective attentional biases in children

968

Anxiety sensitivity, controllability, and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance-abusing veterans

969

Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption

970

Anxiety Sensitivity, State and Trait Anxiety, and Perception of Change in Sympathetic Nervous System Arousal

971

Anxiety sensitivity, state anxiety and perceptions of facial emotions

972

Anxiety sensitivity, suffocation fear, trait anxiety, and breath-holding duration as predictors of response to carbon dioxide challenge

973

Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment

974

Anxiety sensitivity: Concurrent associations with negative affect smoking motives and abstinence self-confidence among young adult smokers

975

Anxiety sensitivity: Confirmatory evidence for a multidimensional construct

976

Anxiety sensitivity: multiple dimensions and hierarchic structure

977

Anxiety sensitivity: Prospective prediction of panic attacks and Axis I pathology

978

Anxiety sensitivity: Relations to psychopathy, DSM-IV personality disorder features, and personality traits

979

Anxiety sensitivity: Relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder

980

Anxiety sensitivity: stability in prospective research

981

Anxiety sensitivity: Theoretical perspectives and recent findings

982

Anxiety sensitivity–physical concerns as a moderator of the emotional consequences of emotion suppression during biological challenge: An experimental test using individual growth curve analysis

983

Anxiety Severity Levels and Coping Strategies during the COVID-19 Pandemic among People Aged 15 Years and Above in Gonabad, Iran

984

Anxiety Status and its Relationship with General Health Related Quality of Life among Prostate Cancer Patients in Two University Hospitals in Kuala Lumpur, Malaysia

985

Anxiety Status of Instagram Users during Coronavirus Disease in Iran in 2020: A Cross-sectional Study

986

Anxiety symptoms among remitted depressed outpatients: Prevalence and association with quality of life and psychosocial functioning

987

Anxiety symptoms and disorder predict activity limitations in the elderly

988

Anxiety symptoms and disorders at eight weeks postpartum

989

Anxiety Symptoms During Adolescence Predicts Salivary Cortisol in Early Adulthood Among Blacks; Sex differences

990

Anxiety symptoms in Japanese and in German children

991

ANXIETY SYMPTOMS IN PATIENTS WITH CONVERSION DISORDER

992

Anxiety symptoms in rural Mexican adolescents

993

Anxiety symptoms of new mothers during a period of recurrent, local terror

994

Anxiety through the Three Trimesters of Pregnancy

995

Anxiety towards Mathematics of Workers in the Production Area of a Sugar Mill in Veracruz, Mexico

996

Anxiety Treatment by Eye Movement Desensitization and Reprocessing in Patients With Myocardial Infarction

997

Anxiety Worsens Prognosis in Patients With Coronary Artery Disease Original Research Article

998

Anxiety, a benefit and detriment to cognition: Behavioral and magnetoencephalographic evidence from a mixed-saccade task

999

Anxiety, affect, depression and cigarette consumption

1000

Anxiety, conscious awareness and change detection

بازگشت